Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.Sweta Chekuri, Harmony R. Reynolds, Alexis F. Turgeon et al.|Bristol Research (University of Bristol)|2021Cited by 589
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19Ewan C. Goligher, Allen Cheng, Patrick R. Lawler et al.|JAMA|2023Cited by 98
Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 ScoreOtávio T. Ranzani, Simon Oczkowski, Mervyn Singer et al.|JAMA|2025Cited by 81
Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational studyLuis Felipe Reyes, Senthilkumar Alegesan, Srinivas Murthy et al.|Critical Care|2022Cited by 46
Continuation of therapeutic dose heparin for critically ill patients with COVID-19Charlotte Bradbury, Edward Litton, Patrick R. Lawler et al.|Intensive Care Medicine|2023Cited by 6